SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001136261-20-000119
Filing Date
2020-05-15
Accepted
2020-05-15 16:58:49
Documents
2
Period of Report
2020-05-15

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 3  
1 PRIMARY DOCUMENT primary_doc.xml 3 1531
2 POA dunn.htm EX-24 3939
  Complete submission text file 0001136261-20-000119.txt   7008
Mailing Address 300 PARK AVENUE NEW YORK NY 10017
Business Address 300 PARK AVENUE NEW YORK NY 10017 (646) 998-6475
SEELOS THERAPEUTICS, INC. (Issuer) CIK: 0001017491 (see all company filings)

IRS No.: 870449967 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O SEELOS THERAPEUTICS, INC. 300 PARK AVENUE, 12TH FLOOR NEW YORK NY 10022
Business Address
Dunn Judith (Reporting) CIK: 0001811904 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-22245 | Film No.: 20886466